Moderna Inc. Stock
€23.79
Your prediction
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.Not a member yet? Sign up for free!
Financial data and news for Moderna
sharewise wants to provide you with the best news and tools for Moderna, so we directly link to the best financial data sources.
Financials
News
Telemark Asset Management Builds Position in Beaten-Down Biotech Stock.
Telemark Asset Management, LLC established a new position in Moderna (NASDAQ:MRNA), acquiring 500,000 shares valued at approximately $12.91 million as of September 30, 2025, according to a November
Prediction: Moderna Will Soar Over the Next 5 Years. Here's 1 Reason Why.
Long gone are the days when Moderna (NASDAQ: MRNA) would generate over $18 billion in annual sales from its COVID-19 vaccine. Over the past couple of years, the company's revenue and earnings have
Should You Buy Moderna Right Now?
Has Moderna (NASDAQ: MRNA) finally bottomed out? You may be asking that yourself right now, as shares in the biotech company have held steady at around $25 per share over the past six months.
These 3 Beaten-Down Healthcare Stocks Could Have Farther to Fall
"Buying the dip" can be a double-edged sword for investors. Sometimes they can seize the opportunity by purchasing an oversold stock, but other times, that stock is trending lower for a good reason
Why Moderna Might Be a One-Hit Wonder
Can you believe that Moderna (NASDAQ: MRNA) was once worth more than $195 billion in 2021? Back then, the business looked on track to be the next big healthcare company.
Then, demand for its
2 Beaten-Down Stocks to Buy and Hold for a Decade
Over the past couple of years, Moderna (NASDAQ: MRNA) and Regeneron Pharmaceuticals (NASDAQ: REGN) have encountered company-specific headwinds that have sunk their stock prices. The former is down
Is it Time to Dump Your Shares of Moderna?
Although you may not exactly understand what Moderna (NASDAQ: MRNA) does, you probably know the company's name, given its involvement in the coronavirus pandemic. The messenger RNA technology, or
If You're in Your 30s, Consider Buying These 2 Healthcare Stocks
Investing styles tend to evolve as people age. Seniors who are already retired often look for steady, reliable, dividend-paying companies. Younger investors, on the other hand, can afford to take
The 3 Things That Matter for Moderna Now
Since hitting their peak in late 2021, Moderna's (NASDAQ: MRNA) shares are down by more than 90%. The biotech company gained recognition by developing one of the leading coronavirus vaccines on the
Down 74% Over the Past Year, Is Moderna Stock a Buy?
In the short term, Moderna (NASDAQ: MRNA) looks like a bad bet. It's coming off of the momentum of its COVID-19 vaccine, and doesn't have a lot of new ammo ready yet to expand in new directions. I
Where Will Moderna Be in 10 Years?
A lot can happen in 10 years, and that's good news for a struggling stock like Moderna (NASDAQ: MRNA). Once a stock market star generating billions of dollars in coronavirus vaccine revenue, Moderna
Why Moderna Stock Was So Healthy This Week
Moderna (NASDAQ: MRNA), the next-generation healthcare company most famous for developing the Spikevax coronavirus vaccine, was an uncharacteristically popular stock. Investors piled into its shares
Is it Time to Dump Your Shares of Moderna?
After soaring to success in the early days of the COVID-19 pandemic, Moderna (NASDAQ: MRNA) experienced a reversal of fortune. The coronavirus vaccine maker has seen revenue plummet as demand for